Article Category: Drugs

Great expectations? How carers view Aricept

When new drug treatments for Alzheimer’s disease were launched last year, professionals feared that all the publicity could create false hopes among carers and relatives. However, this study by Frances Vaughan, Robert Jones and Louise Cunliffe showed that most carers’ expectations were consistent with the clinical information they had been given. Author/s: Frances Vaughan, Robert...

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now

Haloperidol, hips and toenails

Mrs T’s “calming” medication was having the opposite effect and she posed a huge challenge for staff. Without the drug she began to emerge as a person, and staff could begin a long but effective process of discovery and individualised care. By Tracy Packer and Michelle Jefferies. Author/s: Tracy Packer, Michelle Jefferies For the full...

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now

Antipsychotic drugs: their use and misuse

Do antipsychotic drugs have a role in good dementia care practice? Following warnings of overuse in some care settings, Marc Lestor and James Warner give guidance on when these drugs may be effective and useful, and when they should not be used. Author/s: Marc Lestor, James Warner For the full article please see the PDF...

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now

Launched with a quiet fanfare

Excitement was kept under firm control at the launch of the first UK drug for Alzheimer’s disease. For a lucky few it is certainly beneficial, but as potential demand is so huge, financial and ethical issues must be faced. Robert Short describes the effects and efficacy of donepezil (Aricept). Author/s: Robert Short For the full...

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now

A small step forward

Aricept may be good news in the long term, but for now it will increase demands on hard-pressed services, writes Harry Cayton. Author/s: Harry Cayton For the full article please see the PDF download linked to the right. The full JDC archive is available if you subscribe....

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now

Prescribing a hazy future

The use of drugs to improve cognitive ability raises important ethical questions. Anthea Tinker and colleagues outline the issues we should all urgently consider. Author/s: Anthea Tinker For the full article please see the PDF download linked to the right. The full JDC archive is available if you subscribe....

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now

How and why to keep taking the tablets

Many people with dementia also have physical conditions needing regular medication, but their ability to take drugs regularly, and as instructed, is impaired. Alison Ewing explains how a pharmacist can help, and describes the variety of compliance aids available. Author/s: Alison Ewing For the full article please see the PDF download linked to the right....

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now

Many a slip ‘twixt dose and lip

Monitored dosage is a useful time-saving system of drug administration, but it does bring its own limitations and dangers. Sally Kennedy shares some words of warning after using the system for five years. Author/s: Sally Kennedy For the full article please see the PDF download linked to the right. The full JDC archive is available...

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now

Understanding dementia 9: Drug treatments for psychiatric and behaviour disturbances

Dr Robert Tobiansky reviews research and clinical experience on the use of drugs to help carers and staff cope with behaviour disturbances in dementia. Author/s: Robert Tobiansky For the full article please see the PDF download linked to the right. The full JDC archive is available if you subscribe....

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now

Understanding dementia 10

Drug treatments for depression and anxiety, and use of hypnotic drugs. Author/s: Robert Tobiansky For the full article please see the PDF download linked to the right. The full JDC archive is available if you subscribe....

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now